Actigraphic Measurement of a Neurosurgical Procedure
Study Details
Study Description
Brief Summary
The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Actigraphic measurements, repeated verbal fluency and multi-symptom operationally defined observations will be recorded for an 11 to 12 day baseline period and continued following neurosurgical tumor resection until a repeat MRI is completed three months after the procedure.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Actigraphic Neurosurgical Outcomes Actigraphic measurements that will be obtained by attaching the actigraphic watch device to the individual's non-dominant wrist and operationally defined repeated observational measurements. All measurements will continue through a baseline period and continue through the identified post surgical period. Actigraphic measurements will occur every 30 seconds with brief periods of non-measurement during the actual neurosurgical procedure and periods when the actigraphic device has reached storage capacity (approximately every 22 days) when data is retrieved and the device prepared resume measurements. |
Procedure: Re-section of a large left anterior cranial fossa meningioma
Neurosurgical re-section of an incidental large left anterior cranial fossa meningioma
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Pre and Post Actigraphic and Systematic Observation Scale measurements [March 15, 2009-June 20, 2009]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of incidental meningioma
-
Single subject preparing to receive neurosurgical intervention
Exclusion Criteria:
- Inability to wear actigraphy device
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Child Psychopharmacology Institute | Fargo | North Dakota | United States | 58103 |
Sponsors and Collaborators
- Child Psychopharmacology Institute
- Mayo Clinic
Investigators
- Principal Investigator: Bill J Duke, M.A., Ph.D., Child Psychopharmacology Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Act2NS